Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Accured Expenses (2019 - 2025)

Black Diamond Therapeutics' Change in Accured Expenses history spans 5 years, with the latest figure at $582000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 125.72% year-over-year to $582000.0; the TTM value through Dec 2025 reached -$1.4 million, down 87.04%, while the annual FY2025 figure was -$1.4 million, 87.04% down from the prior year.
  • Change in Accured Expenses reached $582000.0 in Q4 2025 per BDTX's latest filing, up from -$1.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.8 million in Q1 2021 to a low of -$2.3 million in Q1 2025.
  • Average Change in Accured Expenses over 3 years is $74000.0, with a median of $582000.0 recorded in 2025.
  • Peak YoY movement for Change in Accured Expenses: surged 194.19% in 2021, then plummeted 226.97% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at $2.8 million in 2021, then crashed by 179.8% to -$2.3 million in 2024, then soared by 125.72% to $582000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Change in Accured Expenses are $582000.0 (Q4 2025), -$1.5 million (Q3 2025), and $1.8 million (Q2 2025).